Although there is no previous report that MSC infusion can induce thrombotic events, the platelet count on set was low, and there was no previous history of cardiovascular disease or risk factors, so UC-MSC infusion could not be ruled out.22 Notably, 22.2% of the subjects reported elevated liver transaminase (all incidents were Grade 1 AEs) during the observation period, which were considered related to the long-term use of concomitant drugs (danazol or TPO-RAs). The gene discussed is TPO; the disease is cardiovascular disorder.